Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Flavonoids as P-glycoprotein inhibitors for multidrug resistance in cancer: an in-silico approach

19 Sept 2022

Abstract excerpt

Cancer has become a leading cause of mortality due to non-communicable diseases after cardiovascular disease worldwide and is increasing day by day at a daunting pace. According to an estimate by 2040 there will be 28.4 million cancer cases. Occurrence of multidrug resistance has further worsened the scenario of available cancer treatment. Among different mechanisms of multidrug resistance efflux of xenobiotics...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Drug Transport and Resistance Mechanisms
Share to Synthesis and biological activity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36120941
DOI: 10.1080/07391102.2022.2123390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Flavonoids as P-glycoprotein inhibitors for multidrug resistance in cancer: an in-silico approachPMID 36120941Read ↗

Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancerSemantic proximity Read ↗

Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)Semantic proximity Read ↗

Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug ResistanceSemantic proximity Read ↗

Reversal of Multidrug Resistance in Cancer by Multi-Functional FlavonoidsSemantic proximity Read ↗

Advances in plant-based inhibitors of P-glycoproteinSemantic proximity Read ↗

New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in CancerSemantic proximity Read ↗

Quercetin acts as a P-gp modulator via impeding signal transduction from nucleotide-binding domain to transmembrane domainSemantic proximity Read ↗

Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review)Semantic proximity Read ↗

Flavonoids as omnipotent candidates for cancer managementSemantic proximity Read ↗

Taxifolin Resensitizes Multidrug Resistance Cancer Cells via Uncompetitive Inhibition of P-Glycoprotein FunctionSemantic proximity Read ↗

Clinically-Relevant ABC Transporter for Anti-Cancer Drug ResistanceSemantic proximity Read ↗

Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.